A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly’s and Novo’s GLP-1 Duopoly
You probably already know that pharmaceutical powerhouses Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) dominate the anti-obesity drug…
Tag: Novos
Novo’s Wegovy to Be Offered Far More Widely on England’s NHS
Novo Nordisk A/S’s obesity drug Wegovy will be an option for about 1.2 million more patients in England’s National Health…
Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy
Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for…
Hims & Hers shares tick lower after Novo’s legal threat. Here’s the latest
Rafael Henrique | SOPA Images | AP The stock of Hims & Hers fell Friday after a legal threat from…
Medicare Negotiates 71% Discount on Novo’s Ozempic, Wegovy
The US government said it negotiated a 71% discount on Novo Nordisk A/S’s blockbuster Ozempic and Wegovy drugs for patients…
Novo’s Ozempic Pill Fails to Slow Alzheimer’s in Studies
A pill version of Novo Nordisk’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of trials.…
Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer
Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover…
Meta shares fall on AI restructuring report, while Lilly shrugs off Novo’s Ozempic price move
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Novo’s Latest Obesity Drug Shows 24% Weight Loss in Small Trial
Novo Nordisk A/S’s latest experimental obesity drug helped patients lose as much as 24.3% of their weight in a small…